中晚期癌症病人支持性团体心理治疗的对照研究

Contrasted study of supportive group psychotherapy for 68 patients with advanced cancer

目的探讨支持性团体治疗对中晚期癌症病人的效果。方法将68例中晚期癌症病人随机分为两组。对照组接受常规化疗;实验组除接受常规化疗外同时参加为期8周、每周2次的支持性团体心理治疗。比较两组病人于治疗前后焦虑、抑郁水平,整体生活质量和免疫功能有无差异。结果经过8周的支持性团体心理治疗后,实验组病人的焦虑、抑郁水平显著低于对照组(SAS,P<0.01;SDS,P<0.05);整体生活质量显著高于对照组(P<0.01);细胞免疫中的CD16水平显著高于对照组(P<0.01)。结论支持性团体心理治疗可以缓解中晚期癌症病人的焦虑和抑郁,提高整体生活质量和NK细胞水平,可作为癌症治疗的辅助方法。

Objective To investigate the effectiveness of Supportive group therapy for patients with advanced cancer. Methods 68 patients with advanced cancer were randomized to Supportive group psychotherapy （SGP） or to control group with a 8-week observation. Rating Scale and Lab test was assessed and compared independently both at baseline and at the end of 8th week, included the SAS,SDS,QLQ and immune function. Results Compared to controls, after 8-week SGP, the trail group reduced more in the scores at anxiety （P〈0.01,） and depression （P〈 0.05, ）, and showed a significant improvement in quality of life and the level of CD16. Conclusions SGP, for patients with advanced cancer, can lessen anxiety and depression mood and build global quality of life. SGP can also increase the CD16 level in the patients. Its suggest SGP can be used as a supplementary therapy for patients with terminal diseases to improve their quality of life.